Learn more at LeadIQ.com

Insights

Market Expansion Artiva Biotherapeutics is actively expanding its market presence by developing off-the-shelf, allogeneic NK cell therapies for autoimmune diseases and cancers, creating potential sales opportunities in the growing immunotherapy market.

Financial Growth With a funding of $120 million and a revenue ranging from $10 million to $50 million, Artiva Biotherapeutics has a solid financial foundation, indicating stability and potential for significant future sales growth.

Strategic Partnerships Collaborations with organizations like Lupus Therapeutics for clinical trials open doors for potential partnership-driven sales opportunities, leveraging the expertise and resources of both parties for mutual benefits.

Key Personnel Appointing experienced individuals like Alison Moore as an independent member of the Board of Directors and Neha Krishnamohan as CFO demonstrates a focus on leadership strength, which can enhance credibility and sales prospects.

Public Offering Success The successful IPO raising $167 million indicates investor confidence in Artiva Biotherapeutics' vision and potential, laying the groundwork for increased market visibility and potential collaborations or sales opportunities.

Similar companies to Artiva Biotherapeutics

Artiva Biotherapeutics Tech Stack

Artiva Biotherapeutics uses 8 technology products and services including Site Kit, MySQL, NetSuite, and more. Explore Artiva Biotherapeutics's tech stack below.

Site Kit
Analytics
MySQL
Database
NetSuite
E-commerce
Polyfill
Javascript Libraries
RSS
Miscellaneous
Smartsheet
Project Management
X-XSS-Protection
Security
WPMU DEV Smush
Web Platform Extensions

Media & News

Artiva Biotherapeutics's Email Address Formats

Artiva Biotherapeutics uses at least 1 format(s):

Artiva Biotherapeutics Email Formats	Example	Percentage
FLast@artivabio.com	JDoe@artivabio.com	50%
FLast@artivabio.com	JDoe@artivabio.com	50%

Frequently Asked Questions

Where is Artiva Biotherapeutics's headquarters located?

Artiva Biotherapeutics's main headquarters is located at 5505 Morehouse Drive, Suite 100 San Diego, California 92121 US. The company has employees across 3 continents, including North AmericaEuropeAfrica.

What is Artiva Biotherapeutics's stock symbol?

Artiva Biotherapeutics is a publicly traded company; the company's stock symbol is ARTV.

What is Artiva Biotherapeutics's official website and social media links?

Artiva Biotherapeutics's official website is artivabio.com and has social profiles on LinkedIn.

How much revenue does Artiva Biotherapeutics generate?

As of September 2024, Artiva Biotherapeutics's annual revenue reached $15M.

What is Artiva Biotherapeutics's SIC code NAICS code?

Artiva Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Artiva Biotherapeutics have currently?

As of September 2024, Artiva Biotherapeutics has approximately 82 employees across 3 continents, including North AmericaEuropeAfrica. Key team members include Chief Operating Officer: J. B.Chief Financial Officer: M. F.Chief Medical Officer: T. G.. Explore Artiva Biotherapeutics's employee directory with LeadIQ.

What industry does Artiva Biotherapeutics belong to?

Artiva Biotherapeutics operates in the Biotechnology Research industry.

What technology does Artiva Biotherapeutics use?

Artiva Biotherapeutics's tech stack includes Site KitMySQLNetSuitePolyfillRSSSmartsheetX-XSS-ProtectionWPMU DEV Smush.

What is Artiva Biotherapeutics's email format?

Artiva Biotherapeutics's email format typically follows the pattern of . Find more Artiva Biotherapeutics email formats with LeadIQ.

How much funding has Artiva Biotherapeutics raised to date?

As of September 2024, Artiva Biotherapeutics has raised $120M in funding. The last funding round occurred on Feb 26, 2021 for $120M.

When was Artiva Biotherapeutics founded?

Artiva Biotherapeutics was founded in 2019.

Artiva Biotherapeutics

Artiva Biotherapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Artiva Biotherapeutics is an immunotherapy company with the ability to produce off-the-shelf, allogeneic NK cell therapies at a massive scale. Our mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. Our lead program, AlloNK®, is an allogeneic, non-genetically modified NK cell therapy candidate designed to enhance the activity of monoclonal antibodies or NK cell engagers. AlloNK is currently in clinical trials in combination with rituximab for treatment of systemic lupus erythematosus (SLE) in patients with active lupus nephritis and for treatment of Non-Hodgkin Lymphoma, as well as in combination with Affimed’s innate cell engager AFM13 for the treatment of patients with relapsed/refractory CD30-positive lymphomas.

Company Overview

Headquarters: 5505 Morehouse Drive, Suite 100 San Diego, California 92121 US
Website: artivabio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ARTV
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2019
Employees: 51-200

Media & News

Funding & Financials

$120M
Artiva Biotherapeutics has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Feb 26, 2021 in the amount of $120M.
$10M$50M
Artiva Biotherapeutics's revenue is in the range of $10M$50M

Funding & Financials

$120M
Artiva Biotherapeutics has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Feb 26, 2021 in the amount of $120M.
$10M$50M
Artiva Biotherapeutics's revenue is in the range of $10M$50M

Company Leadership

J. B.
Chief Operating Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. F.
Chief Financial Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. G.
Chief Medical Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. V.
Vice President Of Corporate Development & Allonk Program Lead
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. S.
Head Of Manufacturing Sciences
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

T. G.
Chief Medical Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
Director Of Information Technology (head Of It)
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. R.
Senior Vice President, Research And Early Development
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. S.
Head Of Manufacturing Sciences
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. H.
Senior Vice President, Regulatory Affairs
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.